GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » YoY EBITDA Growth

Neurologix (Neurologix) YoY EBITDA Growth : -29.11% (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Neurologix's YoY EBITDA Growth for the quarter that ended in Jun. 2011 was -29.11%.

Neurologix's EBITDA per Share for the three months ended in Jun. 2011 was $-0.10.


Neurologix YoY EBITDA Growth Historical Data

The historical data trend for Neurologix's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix YoY EBITDA Growth Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.91 1.84 8.99 -56.38 14.21

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.85 26.80 33.67 35.14 -29.11

Neurologix YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Neurologix's YoY EBITDA Growth for the fiscal year that ended in Dec. 2010 is calculated as:

YoY EBITDA Growth (A: Dec. 2010 )
=(EBITDA per Share (A: Dec. 2010 )-EBITDA per Share (A: Dec. 2009 ))/ | EBITDA per Share (A: Dec. 2009 ) |
=(-0.326--0.38)/ | -0.38 |
=14.21 %

Neurologix's YoY EBITDA Growth for the quarter that ended in Jun. 2011 is calculated as:

YoY EBITDA Growth (Q: Jun. 2011 )
=(EBITDA per Share (Q: Jun. 2011 )-EBITDA per Share (Q: Jun. 2010 )) / | EBITDA per Share (Q: Jun. 2010 )) |
=(-0.102--0.079)/ | -0.079 |
=-29.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Neurologix's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines